Flash FinanceUS
Market closed · weekend S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026

Pediatrix Medical Group (MD)

NYSE Health Care Health Care Services S&P SmallCap 600
$31.29
-0.55 (-1.73%)
Close of Nov 06, 2026 · end-of-day data
Source: Pediatrix Medical Group's 10-K / 10-Q XBRL data on SEC EDGAR · fetched Nov 06, 2026

Revenue, net income & free cash flow

Income statement

fiscal years · USD
Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue$3.18B$3.25B$1.72B$1.78B$1.73B$1.91B$1.97B$1.99B$2.01B$1.91B
Operating income$571.69M$454.89M$248.39M$171.76M$98.13M$202.92M$172.69M$7.32M-$68.71M$208.81M
Interest expense$63.09M$74.56M$92.94M$118.93M$110.48M$68.72M$39.70M$42.08M$40.74M$35.97M
Pre-tax income$513.80M$385.67M$166.21M$58.78M$7.15M$135.23M$81.37M-$48.36M-$101.34M$216.43M
Income tax$189.20M$80.23M$44.69M$16.58M$16.73M$27.24M$18.81M$12.05M-$2.27M$51.04M
Net income$324.91M$320.37M$268.63M-$1.50B-$796.49M$130.96M$66.33M-$60.41M-$99.07M$165.39M
EBITDA$660.95M$533.75M$272.74M$197.69M$126.57M$235.06M$208.32M$43.49M-$36.49M$230.64M
EPS (basic)$3.52$3.47$2.95$-17.94$-9.55$1.54$0.79$-0.73$-1.19$1.97
EPS (diluted)$3.49$3.45$2.93$-17.83$-9.55$1.53$0.79$-0.73$-1.19$1.94
Diluted shares93.11M92.96M91.61M84.01M83.39M85.83M84.12M82.20M83.33M85.43M
Operating margin18.0%14.0%14.4%9.7%5.7%10.6%8.8%0.4%-3.4%10.9%
Net margin10.2%9.8%15.6%-84.2%-45.9%6.9%3.4%-3.0%-4.9%8.6%

Balance sheet

fiscal years · USD
Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash & equivalents$55.70M$40.45M$40.77M$107.87M$1.12B$387.39M$9.82M$73.26M$229.94M$375.24M
Short-term investments——$21.92M$0$104.87M$99.72M$93.24M$104.48M$118.57M$124.48M
Receivables$495.28M$504.00M$506.72M$434.27M$241.93M$301.77M$296.79M$272.31M$259.99M$229.66M
Total current assets$587.13M$627.24M$659.98M$731.51M$1.55B$840.56M$427.99M$483.45M$639.61M$763.51M
Goodwill$3.85B$4.28B$4.06B$1.48B$1.48B$1.51B$1.53B$1.38B$1.24B$1.26B
Total assets$5.34B$5.87B$5.94B$4.15B$3.35B$2.72B$2.35B$2.22B$2.15B$2.25B
Total current liabilities$448.95M$531.42M$502.76M$541.82M$444.33M$427.37M$426.98M$388.95M$434.11M$458.91M
Short-term debt$20.00M$1.40M$253.00K——$2.49M$14.90M$14.91M$20.55M$26.81M
Long-term debt$1.68B$1.85B$1.97B$1.70B$1.70B$989.70M$637.20M$622.20M$611.20M$570.53M
Total debt$1.70B$1.85B$1.97B$1.70B$1.70B$992.19M$652.10M$637.11M$631.75M$597.34M
Total liabilities$2.58B$2.80B$2.85B$2.65B$2.60B$1.83B$1.46B$1.37B$1.39B$1.38B
Shareholders' equity$2.76B$3.07B$3.09B$1.50B$747.49M$896.49M$891.63M$849.06M$764.94M$865.85M

Cash flow

fiscal years · USD
Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow$443.78M$511.38M$313.71M$357.71M$204.62M$76.74M$166.94M$137.32M$206.57M$271.09M
Free cash flow$443.78M$511.38M$313.71M$357.71M$204.62M$76.74M$166.94M$137.32M$206.57M$271.09M
Investing cash flow-$821.22M-$576.61M-$142.77M$102.45M$815.51M-$53.07M-$56.95M-$48.18M-$35.41M-$18.30M
Financing cash flow$381.56M$89.74M-$170.61M-$393.07M-$4.16M-$760.12M-$487.55M-$25.71M-$14.48M-$107.49M
Share buybacks$61.83M$70.19M$302.16M$145.28M$8.49M$4.72M$88.51M$919.00K$1.70M$86.68M
Stock-based compensation$34.00M$28.78M$36.59M$33.41M$39.04M$18.97M$16.13M$12.32M$11.87M$18.05M
Depreciation & amortization$89.26M$78.86M$24.36M$25.93M$28.44M$32.15M$35.64M$36.17M$32.23M$21.83M

Quarterly figures are rebuilt from the year-to-date totals companies report — Q4 is the full year minus the first nine months, since no 10-Q is filed for it. Values are as filed; later restatements replace earlier ones. Fiscal years are labelled by the calendar year in which they end.